LevFinIndustrialsSIGNED
Vytrus to expand Terrassa production facility
Value
€4.5M
Target
Vytrus
Vytrus is expanding its new factory in Terrassa with an additional investment of 4.5 million euros. Banco Sabadell will provide the extra resources through a loan.
✦ Meridian Analysis
Vytrus Biotech has signed a €4.5 million loan agreement with Banco Sabadell to fund the second phase of its new Terrassa production facility. The biotech, which listed on BME Growth in 2022, had already committed €3.5 million to the 1,600‑square‑metre plant and secured a €2 million credit line from the Institut Català de Finances (ICF) earlier in the year. The additional loan will cover the installation of extra bioreactors and auxiliary technology, allowing the company to increase output beyond the original target of tripling capacity. The loan supplements the earlier credit facility, and the plant is now expected to be operational before summer 2027.
Vytrus’s rapid revenue growth—€8.64 million in the first nine months of 2026, up 34% year‑on‑year—has been supported by equity from its founders, Zamit Capital, ICF and family offices.
Deal professionals will be looking for the loan’s pricing, tenor and any covenants, none of which were disclosed. Confirmation of the plant’s commissioning timeline will also be key. The identities of any financial advisers or arrangers involved in the loan documentation have not been made public.
The Meridian Weekly
The week's largest deals and the Iberian ones, every Monday. Free.